Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 30
The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim
Mohammed Alrouji, Hayder M. Al‐kuraishy, Abdul-karim Abd Ali Al-Mahammadawy, et al.
Neurological Sciences (2023) Vol. 44, Iss. 11, pp. 3781-3794
Closed Access | Times Cited: 17
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors
Federica Bono, Chiara Fiorentini, Veronica Mutti, et al.
Pharmacological Research (2023) Vol. 190, pp. 106711-106711
Open Access | Times Cited: 11
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease
Eslam El Nebrisi, Yosra Lozon, Murat Öz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3210-3210
Open Access
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Xiangge Guo, Xumeng Wang, Jiaxuan Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3774-3774
Open Access
17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons.
Giulia Sbrini, Veronica Mutti, Federica Bono, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176678-176678
Open Access | Times Cited: 3
Alterations in Neuronal Nicotinic Acetylcholine Receptors in the Pathogenesis of Various Cognitive Impairments
Zhi‐Zhong Guan
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 3
In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Min Lin, Phillip Mackie, Fatima Shaerzadeh, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Changes in smoking, alcohol consumption, and the risk of Parkinson’s disease
Se Young Jung, Sohyun Chun, Eun Bin Cho, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
LRRK2 along the Golgi and lysosome connection: a jamming situation
Giovanni Piccoli, Mattia Volta
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 15
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway
Veronica Mutti, Federica Bono, Zaira Tomasoni, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2129-2149
Open Access | Times Cited: 10
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons
Irene Fasciani, Francesco Petragnano, Federica Bono, et al.
Neuroscience (2024) Vol. 544, pp. 104-116
Open Access | Times Cited: 1
How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types
Hannah M. Bailey, Mark Cookson
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1331-1352
Open Access | Times Cited: 1
The Neuroanatomy of Induced Pluripotent Stem Cells: In Vitro Models of Subcortical Nuclei in Neurodegenerative Disorders
Alessandro Galgani, Marco Scotto, Filippo Sean Giorgi
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10180-10199
Open Access | Times Cited: 1
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function
Federica Bono, Veronica Mutti, Zaira Tomasoni, et al.
Current topics in behavioral neurosciences (2022), pp. 47-72
Closed Access | Times Cited: 4
Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine
Federica Bono, Cristina Missale, Chiara Fiorentini
Neural Regeneration Research (2021) Vol. 17, Iss. 4, pp. 767-767
Open Access | Times Cited: 5
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates
Gaia Faustini, Francesca Longhena, Alessia Muscò, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3902-3902
Open Access | Times Cited: 2
Effect of Coffee, Tobacco, and Alcohol on Parkinson’s Disease
Wongi Seol, Hye Jung Kim, Ilhong Son
Journal of the Korean Neurological Association (2021) Vol. 39, Iss. 3, pp. 129-133
Open Access
Synapsin III Controls Early Phases of Dopaminergic Neurons Development in Fishes and Mammals by Acting Upstream of BDNF and Cdk5 Signaling
Gaia Faustini, Francesca Longhena, Alessia Muscò, et al.
SSRN Electronic Journal (2021)
Open Access
Synapsin III Controls Early Phases of Dopaminergic Neurons Development in Fishes and Mammals by Acting Upstream of BDNF and Cdk5 Signaling
Gaia Faustini, Francesca Longhena, Alessia Muscò, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top